-
4 weeks ago | 
bisnow.com | Kristin Wall
Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once the ticket prices have been raised. **Bisnow is a cashless, checkless operation. Please only submit payment via credit card.
-
1 month ago | 
bisnow.com | Kristin Wall
Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once the ticket prices have been raised. **Bisnow is a cashless, checkless operation. Please only submit payment via credit card.
-
1 month ago | 
lexology.com | Sarah Pennington |Paul Jorgensen |Kristin Wall
On March 6, 2025, British Columbia became the second province to announce the signing of a pharmacare agreement with Canada’s federal government. Manitoba was the first province to do so, on February 27, 2025 (our report here). British Columbia’s pharmacare agreementThe agreement follows from a September 2024 Memorandum of Understanding between the British Columbia and federal governments, stating an intention to negotiate a funding agreement (our report here).
-
1 month ago | 
lexology.com | Sarah Pennington |Paul Jorgensen |Kristin Wall
Canada has made wide-ranging amendments to the Food and Drug Regulations (FDR) and the Medical Devices Regulations (MDR). The amendments are intended to deliver on Health Canada’s modernization commitments, codify long-standing policies and practices, and implement regulatory agilities piloted during the COVID-19 pandemic. Some of the amendments are already in force, while others come into force later in 2025, 2026, and 2027.
-
1 month ago | 
lexology.com | Sarah Pennington |Paul Jorgensen |Kristin Wall
On February 27, 2025, the governments of Canada and of the Province of Manitoba announced the first-ever national pharmacare funding agreement. The two governments also announced a funding agreement under the National Strategy for Drugs for Rare Diseases. Pharmacare AgreementAs we reported, An Act respecting pharmacare (the Pharmacare Act) came into force on October 10, 2024.
-
2 months ago | 
bisnow.com | Kristin Wall
Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once the ticket prices have been raised. **Bisnow is a cashless, checkless operation. Please only submit payment via credit card.
-
Jan 16, 2025 | 
jamanetwork.com | Kristin Wall |Kimberly A. Workowski |Marisa Young |Irene Stafford
Point-of-Care Testing to Combat Congenital Syphilis—The Time Is Now US Preventive Services Task Force USPSTF Recommendation: Screening for Syphilis Infection in Pregnant Women US Preventive Services Task Force; Susan J. Curry, PhD; Alex H. Krist, MD, MPH; Douglas K. Owens, MD, MS; Michael J. Barry, MD; Aaron B. Caughey, MD, PhD; Karina W. Davidson, PhD, MASc; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Alex R. Kemper, MD, MPH, MS; Martha Kubik, PhD, RN; Ann E.
-
Dec 11, 2024 | 
openlegalblogarchive.org | Sarah Pennington |Paul Jorgensen |Kristin Wall
Canada’s emerging national systems of pharmacare and public funding for drugs for rare diseases (DRDs) had key developments last week. On December 4, the Minister of Health (Minister) asked Canada’s Drug Agency-L’Agence des médicaments du Canada (CDA-AMC) for advice on a national formulary and a bulk purchasing strategy for pharmacare.
-
Oct 27, 2024 | 
adressa.no | Kristin Wall
Unge som sliter med psykisk lidelse, faller stadig oftere mellom to stoler i det norske helsevesenet, og de må selv betale om de skal få hjelp. Er vi på vei mot et klassedelt helsevesen? Publisert: 27. oktober 2024 kl. 16:05 Norge står overfor en akutt mangel på helsepersonell sett opp mot behovet for helsetjenester. Uten en løsning vil ventelistene vokse, og færre vil få nødvendig behandling.
-
Apr 16, 2024 | 
lexblog.com | Sarah Pennington |Paul Jorgensen |Kristin Wall
Canada’s federal 2024 budget has set aside $1.5 billion over five years to launch pharmacare, which will introduce national universal drug coverage to Canada. As we reported, on February 29, 2024, the federal government tabled Bill C-64, An Act respecting pharmacare (the Pharmacare Act). The Pharmacare Act outlines the first phase of a national universal drug coverage plan in Canada.
